2026-Mar-10
MetrioPharm Announces Change to its Board of Directors
- Mr Christoph von Moos has resigned from the Board of Directors of MetrioPharm AG
Zurich, March 10, 2026 - MetrioPharm AG, a biotech company developing drugs for inflammatory and infectious diseases, announced today that Mr Christoph von Moos has resigned from the Board of Directors of MetrioPharm AG.
Mr von Moos has stepped down from the Board of Directors at his own request with immediate effect. The Board of Directors of MetrioPharm AG has unanimously accepted his resignation. MetrioPharm AG would like to thank Mr von Moos for his many years of support and expertise and wishes him all the best for the future.
Contact
MetrioPharm AG
Corporate Communications
presse@metriopharm.com
www.metriopharm.com
